Advantage Max3 flea and tick treatment

Advantage Max3 is a well-known veterinary treatment designed to protect dogs against fleas, ticks, and lice. Originally developed by the German pharmaceutical giant Bayer, the brand has been a staple in pet care for decades. The product typically contains active ingredients like imidacloprid and permethrin to provide comprehensive protection for pets.

In 2020, Elanco Animal Health completed the acquisition of Bayer's animal health business, making Elanco the current ultimate owner of the Advantage brand. While the brand originated in Germany and much of its specialized chemical manufacturing continues there, Elanco operates a global supply chain with regional distribution and subsidiary management across the Americas and Europe. In Brazil, it is distributed and managed by Elanco's local subsidiary.